No Data
No Data
"Interest rate cuts + Trump's return" two major expectations continue to ferment! Will this benefiting sector see the dawn?
Market participants believe that in recent three years, the biotechnology sector has been underperforming the broader market. Once the expectation of interest rate cuts is raised by the Fed, biotechnology companies, represented by innovative drugs, will have the ability to make up ground.
CVS Health Insiders Sell US$4.2m Of Stock, Possibly Signalling Caution
Over the past year, many CVS Health Corporation (NYSE:CVS) insiders sold a significant stake in the company which may have piqued investors' interest. Knowing whether insiders are buying is usually
Is CVS Health Stock a Buy?
Rising Drug Costs Force a Third of Americans to Leave Prescriptions Unfilled: Report
Earnings Scorecard: Nike Loses Air After Shocker Results Send Shares Sliding
Insulet Tops S&P 500 Growth Chart for Q2 as It Gains Market Share in the Diabetes Space